These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 25884796

  • 1. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
    Asad M, Bhattacharya P, Banerjee A, Ali N.
    BMC Infect Dis; 2015 Apr 17; 15():188. PubMed ID: 25884796
    [Abstract] [Full Text] [Related]

  • 2. Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses.
    Banerjee A, De M, Ali N.
    J Immunol; 2008 Jul 15; 181(2):1386-98. PubMed ID: 18606693
    [Abstract] [Full Text] [Related]

  • 3. Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.
    Gangneux JP, Sulahian A, Garin YJ, Derouin F.
    Trans R Soc Trop Med Hyg; 1996 Jul 15; 90(5):574-7. PubMed ID: 8944278
    [Abstract] [Full Text] [Related]

  • 4. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.
    Islamuddin M, Chouhan G, Farooque A, Dwarakanath BS, Sahal D, Afrin F.
    PLoS Negl Trop Dis; 2015 Jan 15; 9(1):e3321. PubMed ID: 25568967
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M, Chouhan G, Want MY, Ozbak HA, Hemeg HA, Afrin F.
    PLoS Negl Trop Dis; 2016 Oct 15; 10(10):e0005011. PubMed ID: 27776125
    [Abstract] [Full Text] [Related]

  • 6. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
    Roychoudhury J, Sinha R, Ali N.
    PLoS One; 2011 Mar 10; 6(3):e17376. PubMed ID: 21423750
    [Abstract] [Full Text] [Related]

  • 7. Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters.
    Maes L, Germonprez N, Quirijnen L, Van Puyvelde L, Cos P, Vanden Berghe D.
    Antimicrob Agents Chemother; 2004 Jun 10; 48(6):2056-60. PubMed ID: 15155199
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
    Khadem F, Jia P, Mou Z, Feiz Barazandeh A, Liu D, Keynan Y, Uzonna JE.
    J Antimicrob Chemother; 2017 Feb 10; 72(2):467-477. PubMed ID: 27999013
    [Abstract] [Full Text] [Related]

  • 9. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
    Gangneux JP, Sulahian A, Garin YJ, Farinotti R, Derouin F.
    Antimicrob Agents Chemother; 1996 May 10; 40(5):1214-8. PubMed ID: 8723469
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis.
    Voak AA, Harris A, Qaiser Z, Croft SL, Seifert K.
    Antimicrob Agents Chemother; 2017 Sep 10; 61(9):. PubMed ID: 28630200
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG, Mendonça DVC, Tavares GSV, Lage DP, Dias DS, Ribeiro PAF, Perin L, Ludolf F, Coelho VTS, Ferreira ACG, Neves PHAS, Matos GF, Chávez-Fumagalli MA, Coimbra ES, Pereira GR, Coelho EAF, Antinarelli LMR.
    Exp Parasitol; 2019 Apr 10; 199():30-37. PubMed ID: 30817917
    [Abstract] [Full Text] [Related]

  • 12. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo.
    Kar A, Jayaraman A, Charan Raja MR, Srinivasan S, Debnath J, Mahapatra SK.
    Int Immunopharmacol; 2021 Feb 10; 91():107291. PubMed ID: 33360084
    [Abstract] [Full Text] [Related]

  • 13. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P, Parmar N, Yadav PK, Chandrakar P, Kar S.
    J Mol Med (Berl); 2016 Jun 10; 94(6):695-710. PubMed ID: 26830627
    [Abstract] [Full Text] [Related]

  • 14. Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis.
    Mendonça DVC, Martins VT, Lage DP, Dias DS, Ribeiro PAF, Carvalho AMRS, Dias ALT, Miyazaki CK, Menezes-Souza D, Roatt BM, Tavares CAP, Barichello JM, Duarte MC, Coelho EAF.
    Exp Parasitol; 2018 Mar 10; 186():24-35. PubMed ID: 29448040
    [Abstract] [Full Text] [Related]

  • 15. Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis.
    Murray HW.
    J Immunol; 2005 Apr 15; 174(8):4916-23. PubMed ID: 15814719
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
    Corral MJ, Serrano DR, Moreno I, Torrado JJ, Domínguez M, Alunda JM.
    J Antimicrob Chemother; 2014 Dec 15; 69(12):3268-74. PubMed ID: 25096077
    [Abstract] [Full Text] [Related]

  • 17. Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.
    Das A, Jawed JJ, Das MC, Parveen S, Ghosh C, Majumdar S, Saha B, Bhattacharjee S.
    Cytokine; 2021 Jan 15; 137():155319. PubMed ID: 33002744
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC, de Paula RC, Alves CL, Faria KF, Oliveira MM, Mendes GG, Dias EMFA, Ribeiro RR, Oliveira AB, Silva SMD.
    Exp Parasitol; 2019 Apr 15; 199():67-73. PubMed ID: 30797783
    [Abstract] [Full Text] [Related]

  • 19. Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.
    Gershkovich P, Wasan EK, Sivak O, Li R, Zhu X, Werbovetz KA, Tidwell RR, Clement JG, Thornton SJ, Wasan KM.
    J Antimicrob Chemother; 2010 Mar 15; 65(3):535-7. PubMed ID: 20026611
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effect of ursolic acid in experimental visceral leishmaniasis.
    Jesus JA, Fragoso TN, Yamamoto ES, Laurenti MD, Silva MS, Ferreira AF, Lago JH, Santos-Gomes G, Passero LF.
    Int J Parasitol Drugs Drug Resist; 2017 Apr 15; 7(1):1-11. PubMed ID: 27984757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.